Postpartum hemorrhage - Nursing Case Study

Pathophysiology

• Primary mechanism: Uterine atony, the failure of the uterus to contract effectively after delivery, is the leading cause of postpartum hemorrhage. This can result from overdistention, prolonged labor, or use of certain medications, leading to insufficient compression of the uterine blood vessels and excessive bleeding.

• Secondary mechanism: Retained placental tissue can prevent adequate uterine contraction and involution. When fragments of the placenta remain attached, they can cause continuous bleeding due to disruption of normal hemostatic processes and prolonged exposure of uterine vessels.

• Key complication: Without prompt intervention, these mechanisms can lead to severe hypovolemic shock, disseminated intravascular coagulation (DIC), and organ failure. Early recognition and management are critical to prevent maternal morbidity and mortality.

Patient Profile

Demographics:

32-year-old female, registered nurse

History:

• Key past medical history: History of preeclampsia during pregnancy, gestational diabetes

• Current medications: Labetalol, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe vaginal bleeding post-delivery

• Key symptoms: Dizziness, shortness of breath, severe abdominal pain, fatigue

• Vital signs: Blood pressure 80/50 mmHg, heart rate 130 bpm, respiratory rate 28 breaths/min, temperature 36.8°C, oxygen saturation 89% on room air

Section 1

New Diagnostic Results:

As the medical team quickly mobilizes to address the severe postpartum hemorrhage, critical diagnostic tests are initiated to assess the patient's status and guide treatment decisions. A complete blood count reveals a hemoglobin level of 5.8 g/dL, indicating significant blood loss and severe anemia. The platelet count is notably decreased at 75,000/mm³, raising concerns about the potential development of disseminated intravascular coagulation (DIC). Coagulation studies show an elevated prothrombin time (PT) of 18 seconds and an activated partial thromboplastin time (aPTT) of 45 seconds, further suggesting a derangement in the clotting cascade. Additionally, fibrinogen levels are found to be critically low at 150 mg/dL, supporting the suspicion of consumptive coagulopathy.

A point-of-care ultrasound of the uterus is performed, which confirms significant uterine atony and reveals retained products of conception. These findings are consistent with the secondary mechanism of postpartum hemorrhage and underscore the urgency of addressing the retained placental tissue to restore effective uterine contraction. The patient's arterial blood gas analysis shows a pH of 7.28, indicating metabolic acidosis, likely due to tissue hypoperfusion and lactic acid buildup from hypovolemic shock.

These diagnostic results necessitate an immediate, multifaceted approach to manage the hemorrhage, correct hypovolemia, and address coagulopathy. The healthcare team must prioritize rapid blood transfusion, administration of uterotonics, and potential surgical intervention. These actions are critical to stabilizing the patient and preventing further deterioration, opening a pathway to subsequent decisions regarding her care plan.

Section 2

Change in Patient Status

Despite the rapid initiation of treatment protocols, the patient's condition shows alarming signs of deterioration. Her vital signs indicate significant instability, with a heart rate that has climbed to 140 beats per minute, a blood pressure that has plummeted to 80/50 mmHg, and a respiratory rate that has increased to 30 breaths per minute. The patient is increasingly diaphoretic and exhibits signs of altered mental status, including confusion and a diminished response to verbal stimuli. These clinical indicators suggest the progression of hypovolemic shock and a continued compromise in perfusion, necessitating an aggressive reassessment of the therapeutic approach.

In response to the patient's declining status, the medical team escalates their interventions. The decision is made to transition from initial uterotonic administration to a more invasive surgical strategy, considering the retained products of conception confirmed by ultrasound. The patient is prepared for an emergency exploratory laparotomy, with the goal of removing the retained placental tissue and achieving hemostasis. Concurrently, the transfusion of packed red blood cells, fresh frozen plasma, and platelets is intensified to correct the severe anemia and coagulopathy. Additional laboratory tests are ordered to monitor the patient's coagulation profile and electrolyte balance, as ongoing blood loss and transfusions pose a risk for electrolyte imbalances and other metabolic derangements.

The patient's precarious status and the complexity of her condition demand constant vigilance and advanced clinical judgment. As the team works to stabilize her, they must remain alert for the potential emergence of new complications, such as acute renal failure due to prolonged hypotension or worsening DIC. The unfolding scenario underscores the critical need for a dynamic and coordinated approach, integrating surgical, pharmacological, and supportive care measures to navigate the challenging landscape of severe postpartum hemorrhage.

Section 3

New Diagnostic Results

As the surgical team prepares for the emergency exploratory laparotomy, the latest laboratory results arrive, providing crucial insights into the patient's deteriorating condition. The patient's hemoglobin level has dropped further to 6.5 g/dL, underscoring the severity of her anemia and the urgency of the situation. Coagulation studies reveal a prothrombin time (PT) of 18 seconds and an activated partial thromboplastin time (aPTT) of 45 seconds, indicating a coagulopathy that complicates the management of her postpartum hemorrhage. Fibrinogen levels have also decreased to 150 mg/dL, suggesting a consumptive coagulopathy consistent with disseminated intravascular coagulation (DIC).

Additional electrolyte panels highlight a significant metabolic derangement; the patient's potassium level has risen to 5.8 mmol/L, raising concerns about hyperkalemia, which could potentially lead to cardiac complications. Sodium levels have dropped to 132 mmol/L, indicating hyponatremia, possibly exacerbated by the administration of large volumes of intravenous fluids. These findings necessitate immediate corrective measures to stabilize her electrolyte balance while addressing the ongoing hemorrhagic and coagulopathic challenges.

Armed with these diagnostic results, the medical team recognizes the necessity to adjust their intervention strategies. The administration of cryoprecipitate is initiated to address the low fibrinogen levels, and calcium gluconate is prepared to counteract the effects of hyperkalemia. The team continues to titrate the transfusions of blood products carefully, maintaining a delicate balance to avoid fluid overload while ensuring adequate perfusion and oxygenation. This comprehensive and nuanced approach exemplifies the high level of clinical reasoning required to navigate the complexities of the patient's condition, highlighting the critical need for interdisciplinary collaboration and precise clinical decision-making as they work to stabilize her rapidly evolving clinical status.

Section 4

As the surgical team proceeds with the emergency exploratory laparotomy, the patient's condition continues to evolve, prompting a reassessment of her clinical status. Despite the initiation of cryoprecipitate and calcium gluconate administration, the patient's hemodynamic stability remains precarious. Her blood pressure has dropped further to 80/50 mmHg, and her heart rate has escalated to 130 beats per minute, indicating worsening hypovolemic shock. The oxygen saturation level on high-flow oxygen remains at 92%, suggesting compromised oxygen delivery to vital organs. The decision to intubate is made to ensure adequate airway protection and oxygenation during the surgical intervention.

During the surgery, it is discovered that the patient has an extensive uterine atony coupled with retained placental fragments, contributing significantly to the ongoing hemorrhage. The surgical team swiftly performs a B-Lynch suture to compress the uterus and remove the retained tissue. However, the complexity of the situation is compounded when the patient exhibits signs of acute respiratory distress syndrome (ARDS), likely secondary to massive transfusion and the inflammatory response from DIC. This new complication requires immediate respiratory support and careful fluid management to prevent further pulmonary compromise.

In light of these developments, the medical team works closely with respiratory therapists and critical care specialists to optimize ventilatory strategies and fluid resuscitation. Continuous monitoring of arterial blood gases reveals a pH of 7.29, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicating respiratory acidosis and inadequate gas exchange. The integration of these findings necessitates adjustments in ventilator settings and pharmacologic support to manage the patient's acute respiratory failure while the surgical team continues to address the underlying hemorrhagic causes. This scenario underscores the complex interplay of multiple organ systems affected by the patient's condition, requiring advanced clinical reasoning and interdisciplinary collaboration to guide her through this critical phase.

Section 5

As the surgical team transitions to postoperative care, new diagnostic results reveal critical insights into the patient's evolving condition. A follow-up complete blood count (CBC) shows a hemoglobin level of 6.5 g/dL and a platelet count of 45,000/µL, indicating persistent anemia and thrombocytopenia despite ongoing blood product administration. Additionally, coagulation studies return with a prothrombin time (PT) of 18 seconds and an international normalized ratio (INR) of 1.8, further confirming the diagnosis of disseminated intravascular coagulation (DIC) and necessitating continued coagulation support.

In parallel, a chest X-ray conducted due to the patient's respiratory distress reveals bilateral pulmonary infiltrates consistent with the development of acute respiratory distress syndrome (ARDS). This finding aligns with the arterial blood gas results, prompting the critical care team to adjust the ventilator settings to a lung-protective strategy, employing low tidal volumes and higher positive end-expiratory pressure (PEEP) to improve oxygenation and minimize ventilator-induced lung injury.

The compounding complexities of the patient's condition, including the ARDS and coagulopathy, require the healthcare team to engage in advanced clinical reasoning and swift decision-making. The interdisciplinary team anticipates the potential for multi-organ failure and discusses the need for continuous renal replacement therapy (CRRT) should the patient's renal function deteriorate. The patient's lactate level remains elevated at 4 mmol/L, indicating ongoing tissue hypoperfusion despite aggressive resuscitation efforts. This scenario demands a fine balance between fluid administration and the risk of exacerbating pulmonary edema, underscoring the critical importance of meticulous hemodynamic monitoring and tailored therapeutic interventions to stabilize the patient.